Drug intelligence / Profile preview

4'-O-methylpyridoxine

Development stage
Preclinical
Lead developer
University of Ottawa
Modality
Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics, Small Molecules
Administration
Intravenous, Oral
01

Overview

4'-O-Methylpyridoxine (also known as ginkgotoxin or 4'-MPN) is a naturally occurring small-molecule antivitamin B6 found in the seeds and leaves of *Ginkgo biloba*. It acts as a competitive inhibitor of pyridoxal kinase (PDXK), the enzyme responsible for synthesizing the active cofactor pyridoxal-5'-phosphate (PLP) from vitamin B6. By lowering brain PLP levels, 4'-O-methylpyridoxine reduces the synthesis of gamma-aminobutyric acid (GABA), leading to an imbalance in the GABA/glutamate ratio that can trigger hyperactivity, convulsions, and seizures (ginkgo seed poisoning). In addition to its role as a neurotoxin, radiolabeled [11C]-4'-O-methylpyridoxine is being investigated as a first-in-class PET imaging radiotracer to monitor the PDXK:PDXP activity ratio in vivo, which serves as a biomarker for chemotherapy resistance (such as cisplatin resistance) in non-small cell lung cancer (NSCLC).

Other names
4'-MPN4'-methoxypyridoxine4-methoxymethylpyridoxineginkgotoxin
02

Targets

PDXK (Pyridoxal kinase)

Beyond the preview

Go deeper on 4'-O-methylpyridoxine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 4'-O-methylpyridoxine.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call